Article
Actionable spatial prostanoid barriers constrain BiTE-driven adoptive T cell immunity in intact human tumors
2026-03-30
Abstract excerpt
Adoptive cell therapy (ACT) in solid tumors is limited by tumor microenvironment (TME)-imposed resistance mechanisms that are inadequately addressed by conventional systems. We developed tissue-preserving patient-derived explants (PDEs) from lung and ovarian cancer to interrogate redirected T cell immunity in intact human tissue. Using mesothelin-targeting bispecific T cell engager (BiTE ® , Amgen trademark)-secr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e62ac15b-22bd-5a9b-9575-b6b9bf64422f
- DOI
- 10.64898/2026.03.26.713601
